Chemoinformaics analysis of 1,9-Dideoxyforskohlin
| Molecular Weight | 378.509 | nRot | 2 |
| Heavy Atom Molecular Weight | 344.237 | nRig | 19 |
| Exact Molecular Weight | 378.241 | nRing | 3 |
| Solubility: LogS | -4.148 | nHRing | 1 |
| Solubility: LogP | 3.355 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 61 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 22 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 63.421 |
| nHD | 1 | BPOL | 39.317 |
| QED | 0.589 |
| Synth | 4.783 |
| Natural Product Likeliness | 3.241 |
| NR-PPAR-gamma | 0.016 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.991 |
| Pgp-sub | 0.006 |
| HIA | 0.218 |
| CACO-2 | -4.836 |
| MDCK | 0.0000209 |
| BBB | 0.955 |
| PPB | 0.628707 |
| VDSS | 0.945 |
| FU | 0.436501 |
| CYP1A2-inh | 0.008 |
| CYP1A2-sub | 0.519 |
| CYP2c19-inh | 0.032 |
| CYP2c19-sub | 0.894 |
| CYP2c9-inh | 0.187 |
| CYP2c9-sub | 0.163 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.258 |
| CYP3a4-inh | 0.71 |
| CYP3a4-sub | 0.441 |
| CL | 7.753 |
| T12 | 0.122 |
| hERG | 0.007 |
| Ames | 0.071 |
| ROA | 0.698 |
| SkinSen | 0.076 |
| Carcinogencity | 0.028 |
| EI | 0.016 |
| Respiratory | 0.969 |
| NR-Aromatase | 0.338 |
| Antiviral | Yes |
| Prediction | 0.600146 |